HIV infected patients should start HAART sooner
Study suggests HIV infected patients should start highly active antiretroviral therapy (HAART) sooner. – Under current treatment guidelines, highly active antiretroviral therapy (HAART) should be considered for HIV-infected patients when their CD4+ T-cell counts fall below 350 cells per cubic millimeter (mm3).